Results 41 to 50 of about 4,860 (160)

Yttrium‐90 Selective Internal Radiotherapy for Gastrointestinal Stromal Tumor With Liver Metastasis: A Case Report and Review

Cancer Innovation, Volume 4, Issue 5, October 2025.
Therapeutic protocols are urgent for liver metastases in Gastrointestinal stromal tumors (GIST) patients. This article presents China's first case in GIST liver metastases patients, treating with Yttrium‐90 resin microsphere selective internal radiation therapy, reviews management challenges, and highlights the emerging role of novel therapies to ...
Li Xing, Xiaobin Feng, Lin Zhang, Zheng Mo, Zhuo Yu   +4 more
wiley   +1 more source

Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma [PDF]

, 2014
10.1371/journal.pone.0090909PLoS ONE93 ...
Anthony S W Goh, Asia-Pacific Hepatocellular Carcinoma Trials Group, Donald Y H Poon, Harjit Singh, Hee-Kit Lai, Ho-Seong Han, Khee-Chee Soo, Kiang-Hiong Tay, Maung-Win Khin, Mihir Gandhi, Pierce K H Chow, Richard H G Lo, Say-Beng Tan, Su-Pin Choo, Teong-Guan Lim   +14 more
core   +3 more sources

Novel Use of Bland Trans‐Arterial Embolization for Hepatoblastoma: A Case Report

Pediatric Transplantation, Volume 29, Issue 5, August 2025.
ABSTRACT Background Hepatoblastoma is an embryonal tumor originating from hepatocyte precursors. Surgical resection is the primary treatment. Unresectable cases are treated with chemotherapy combined with liver transplantation. Patients with suboptimal chemotherapy response face limited therapeutic choices.
Dan Pham, Armando Vera, Chong Bin He, Rachel S. Kronenfeld, Alyson Trillo, Taumoha Ghosh, Jennifer Garcia, Akin Tekin, Prasoon Mohan, Lorraine Portelance, Warren Alperstein, Aditi Dhir   +11 more
wiley   +1 more source

First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) [PDF]

, 2012
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Eichler, Katrin, Gallus, Christof, Gruber-Rouh, Tatjana, Hammerstingl, Renate Maria, Mack, Martin G., Vogl, Thomas J., Zangos, Stephan   +6 more
core   +1 more source

Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma

International Journal of Cancer, Volume 156, Issue 12, Page 2416-2428, 15 June 2025.
What's new? In hepatocellular carcinoma, expanded myeloid‐derived suppressor cells (MDSC) relate to aggressiveness and poor prognosis. A global analysis of the different MDSC subsets in hepatocellular carcinoma is, however, missing. In this study, all three subsets of M‐MDSC, PMN‐MDSC, and eMDSC, together with arginase 1 activity, were significantly ...
Marta Chivite‐Lacaba, Iago Justo, Alberto Utrero‐Rico, Oscar Caso, Cecilia González‐Cuadrado, Manuel J. Del Rey, Rocio Laguna‐Goya, Javier Arroyo‐Ródenas, Ángel Alfocea‐Molina, Carlota C. Ruigómez‐Martín, Manuel Serrano, Lorena Pascual‐Palacios, María Esther Mancebo, Estela Paz‐Artal   +13 more
wiley   +1 more source

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization [PDF]

, 2012
International audiencePURPOSE: Identifying gastroduodenal uptake of (99m)Tc-macroaggregated albumin (MAA), which is associated with an increased risk of ulcer disease, is a crucial part of the therapeutic management of patients undergoing ...
Laurence Lenoir, Julien Edeline, Yann Rolland, Marc Pracht, Jean-Luc Raoul, Valérie Ardisson, Patrick Bourguet, Bruno Clément, Eveline Boucher, Etienne Garin   +9 more
core   +1 more source

Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis [PDF]

Journal of Gastrointestinal Surgery, 2016
An obese 55-year-old woman with nonalcoholic fatty liver disease presented 7 years after resection of a T3N1 ileal carcinoid tumor with an elevated chromogranin A, multifocal metastatic disease to the liver, and carcinoid syndrome. She underwent right hepatic artery yttrium-90 (Y90) radioembolization, followed a month later by selective Y90 treatment ...
Maker, Ajay V, August, Carey, Maker, Vijay K, Weisenberg, Elliot   +3 more
openaire   +4 more sources

Consensus recommendations regarding local and metastasis‐directed therapies in the management of relapsed/recurrent Ewing sarcoma

Cancer, Volume 131, Issue 9, 1 May 2025.
ABSTRACT Limited randomized or prospective data are available to guide local/metastasis directed therapy (LMDT) in relapsed/recurrent Ewing sarcoma (RR‐ES), resulting in uncertainty regarding best clinical practice for these patients. This report reviews the available literature on LMDT approaches and provides consensus recommendations regarding ...
Chirag Shah, Shauna R. Campbell, Erin Murphy, Steve Braunstein, Matthew S. Dietz, Odion Binitie, Zachary J. Kastenberg, Jane Yanagawa, Jennifer Halpern, Bela Kis, Stephen Hunt, Fereshteh Yazdanpanah, Ajay Gupta, Matteo Trucco   +13 more
wiley   +1 more source

Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today? [PDF]

, 2010
Hepatocellular carcinoma (HCC) is a primary malignant tumor of the liver that accounts for an important health problem worldwide. Only 10-15% of HCC patients are suitable candidates for hepatic resection and liver transplantation due to the advanced ...
Beatrijs A. Seinstra, Otto M. van Delden, Karel J. van Erpecum, Richard van Hillegersberg, Willem P. Th. M. Mali, Maurice A. A. J. van den Bosch   +5 more
core   +2 more sources

The Third Pillar of Precision Medicine — Precision Delivery

MedComm, Volume 6, Issue 5, May 2025.
For Precision Medicine to reach its full potential, a third pillar called Precision Delivery is starting to evolve to complement the existing two pillars of Precision Diagnosis and Precision Therapy. Precision Delivery will help ensure the right therapy for the right disease will be able to reach the right location at the right time .
Avnesh S. Thakor
wiley   +1 more source